Grant RDF

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...

• A5280 "A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)"
• A5280 "A Prospective, Randomized, Double-Blind Phase II Trial of High-Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)"
• A5361s: Pitavastatin to Reduce Physical Function Impairment and Frailty in HIV (PREPARE)
• A5361s: Pitvastatin to Reduce Physical Function Impairment and Frailty in HIV
• AAAS Fellowship
• AADR Proctor & Gamble Underrepresented Faculty Research Fellowship
• AADR-Anne D. Haffajee Fellowship
• AAHPM Y.C. Ho/Helen & Michael Chiang Foundation 2016 Fellowship Grant
• AALL 1521; A Phase 2 Study of the JAK1/JAK2 Inhibitor Ruxolitinib with Chemotherapy in Children with De Novo High-Risk CRLF2- Rearranged and/or JAK Pathway-Mutant Acute Lymphoblastic Lukemia
• AALL0434-Novartis Pharmaceuticals Corporation
• AALL1331: Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#100135, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
• AALL1621- A Phase 2 Study of Inotuzumab Ozogamicin (NSC#772518, IND#133494) in Children and Young Adults with Relapsed or Refractory CD22+B-Acute Lymphoblastic Leukemia(B-ALL)
• AALL1931 - An Open-Label, Multicenter Study of RC-P in Patients with Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) Following Hypersensitivity to E. Coll-Derived Asparaginases
• AAML 1031 - A Phase III Randomized Trial for Patients with De Novo AML Using Bortezomib (NSC# 681239) and Sorafenib (BAY 43-9006, NSC# 724772) for Patients with High Allelic Ratio FLT2/ITD
• AAML 1031 - Bayer
• AAML1031: One Time EOY, Integrated BIQSFP AAML1031-Echocardiogram Reports and Images
• AANP Neurodegenerative Disease Scholars Program
• AAV-Based Plasmacytoid Dentritic Cell Cancer Vaccine
• AAV-Mediated Gene Therapy for Metabolic Bone Disease
• Abbott Fund Interventional Fellowship Grant 2017-2018
• Abbott Fund Interventional Fellowship Grant 2018-2019
• Abbott Interventional Fellowship 2012/2013
• Abbott Interventional Fellowship Grant 2013-2014
• Abbott Interventional Fellowship Grant 2014-2015
• Abbott Interventional Fellowship Grant 2015-2016
• Abbott Interventional Fellowship Grant 2016-2017
• Abbott Interventional Fellowship Grant 2020 - 2021
• Aberrant Circadian Regulation Of Autophagy In The Heart During Diabetes
• Aberrant NFkB Signaling in Alzheimer's Disease and its Effects on Neural Stem Cells.
• Abnormal Cytokine Response and Autoantigen Production in IgA-Producing Subpopulations in IgA Nephropathy

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...